We also found that the proportion of CD3+ CD4+ T cells decreased significantly in colon cancer, primary liver cancer and lung cancer (p < 0.05), while the percentage of CD3+ CD8+ T cells increased significantly in primary liver cancer and lung cancer (p < 0.05). This evidence concerns the gene CD4 and liver cancer.